MediXall (MDXL) Shares Outstanding (Diluted Average) (2021 - 2024)
MediXall's Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $145.1 million for Q3 2024.
- For Q3 2024, Shares Outstanding (Diluted Average) rose 15.12% year-over-year to $145.1 million; the TTM value through Sep 2024 reached $145.1 million, up 15.12%, while the annual FY2023 figure was $127.2 million, 9.0% up from the prior year.
- Shares Outstanding (Diluted Average) reached $145.1 million in Q3 2024 per MDXL's latest filing, up from $138.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $145.1 million in Q3 2024 to a low of $101.2 million in Q2 2021.
- Average Shares Outstanding (Diluted Average) over 4 years is $120.9 million, with a median of $119.5 million recorded in 2022.
- Peak YoY movement for Shares Outstanding (Diluted Average): grew 6.6% in 2023, then grew 15.12% in 2024.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $104.2 million in 2021, then increased by 11.96% to $116.7 million in 2022, then grew by 9.0% to $127.2 million in 2023, then rose by 14.11% to $145.1 million in 2024.
- Per Business Quant, the three most recent readings for MDXL's Shares Outstanding (Diluted Average) are $145.1 million (Q3 2024), $138.8 million (Q2 2024), and $134.0 million (Q1 2024).